Bayer is Taking Collaboration with Health Care Start-Ups to the Next Level

BayerAs a pioneer when it comes to collaborating with digital health start-ups, Bayer is now taking the next step. Instead of one-off startup programs, it is now focusing on collaborating in specific digital health focus areas, e.g. digital therapeutics, AI for drug discovery, and patient engagement platforms to name a few. To do this, Bayer is combining the G4A programs and concentrating on longer-term collaborations and investments. "The digital health ecosystem has matured over the years and there are some very well developed start-ups across the value chain. We wanted to simplify the process for entrepreneurs to work with Bayer and scale innovative solutions together, faster. That's why it's time to take the way we collaborate to the next level," says Eugene Borukhovich, Global Head of Digital Health at Bayer.

The three existing programs (Accelerator, Dealmaker and Generator) are being combined to form G4A Partnerships, a joint initiative aimed at start-ups in the health care sector at various stages of development. Specific business challenges will be defined for which the start-ups can put forward their proposed solutions. The most suitable approaches will then be developed further in collaborative teams with Bayer. The cooperation will be underpinned by a letter of intent. Not only will the start-ups be given one-time initial funding (EUR 50,000 to EUR 100,000), they will also receive additional payments when jointly defined milestones are reached. The first business challenges will be announced at the beginning of April.

"For us, it's all about developing new health solutions that can change the experience of health," says Dr. Zsuzsanna Varga who's heading G4A Partnerships. "We're convinced that long-term collaborations with digital health companies sharing the same passion and vision are the best way to achieve this."

About G4A

Bayer is combining the Group's digital health initiatives under the name G4A (formerly Grants4Apps). In addition to identifying new technologies, business models and market trends, these initiatives also involve collaborating with start-ups. Since its launch in 2013, Bayer has supported over 149 digital health companies. This has resulted in 29 direct collaborations with companies such as Agamon, KinAptic,Turbine, and xbird. Bayer now operates G4A in 12 countries, developing and promoting collaborative health care projects around the world. G4A.Health

About Bayer

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population. At the same time, the Group aims to increase its earning power and create value through innovation and growth. Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2018, the Group employed around 117,000 people and had sales of 39.6 billion euros. Capital expenditures amounted to 2.6 billion euros, R&D expenses to 5.2 billion euros.

Most Popular Now

Apple Health Records Available for Allsc…

Allscripts (NASDAQ: MDRX) announced that Apple Health Records is now available for Allscripts Sunrise™, TouchWorks® and Professional EHR™ clients and their patients. Health Records brings together hospitals, clinics and the...

Philips Signs Agreement to Create Taiwan…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that Taipei Veterans General Hospital (TPVGH) will utilize the Philips IntelliSite Pathology Solution to transform its...

Machine Learning Improves the Diagnosis …

Researchers from Charité - Universitätsmedizin Berlin and the German Cancer Consortium (DKTK) have successfully solved a longstanding problem in the diagnosis of head and neck cancers. Working alongside colleagues from...

Robotic Thread is Designed to Slip throu…

MIT engineers have developed a magnetically steerable, thread-like robot that can actively glide through narrow, winding pathways, such as the labrynthine vasculature of the brain. In the future, this robotic...

St Helens and Knowsley Advance with Ambi…

St Helens and Knowsley Teaching Hospitals NHS Trusthas successfully gone live with System C’s CareFlow Vitals as part of its ambitious strategy to accelerate digitisation and become a digital exemplar...

The Future of Mind Control

Electrodes implanted in the brain help alleviate symptoms like the intrusive tremors associated with Parkinson's disease. But current probes face limitations due to their size and inflexibility. "The brain is...

Experimental Validation Confirms the Abi…

Insilico Medicine, a global leader in artificial intelligence for drug discovery, today announced the publication of a paper titled, "Deep learning enables rapid identification of potent DDR1 kinase inhibitors," in...

Using a Smartphone to Detect Norovirus

A little bit of norovirus - the highly infectious microbe that causes about 20 million cases of food poisoning in the United States each year - goes a long way...

Medical Informatics Europe Conference 20…

28 April - 1 May 2020, Geneva, Switzerland. The European Federation of Medical Informatics (EFMI) presents the 30th Medical Informatics Europe conference (MIE) at the Geneva International Conference Center (CICG). This...

Computer Model could Help Test New Sickl…

A team of Brown University researchers has developed a new computer model that simulates the way red blood cells become misshapen by sickle cell disease. The model, described in a...